Triple Antigen vs Monoantigen Immunotherapy for Warts
NCT05254561
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
160
Enrollment
OTHER_GOV
Sponsor class
Conditions
Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts
Interventions
BIOLOGICAL:
Intralesional antigen immunotherapy
Sponsor
Zagazig University